Cancer treatment has come a long way from a one-size-fits-all approach. Today, medicine is moving towards personalized therapy—treatments tailored to the unique genetic makeup of each patient’s cancer. One of the most powerful tools driving this shift is Next Generation Sequencing (NGS).
NGS doesn’t just look at cancer—it looks deeper, scanning the DNA itself to identify genetic mutations that could influence how the disease behaves and how it responds to specific treatments. This precision is helping doctors make smarter, faster, and more targeted treatment decisions, improving patient outcomes.
What is Next Generation Sequencing (NGS)?
Next Generation Sequencing (NGS) is an advanced DNA analysis method that examines the genetic blueprint of a tumor. Think of it like scanning a barcode—just as a barcode reveals a product’s details, NGS decodes the genetic information hidden in a patient’s DNA.
In the context of cancer care, this means detecting mutations, deletions, and alterations in genes that might be driving the growth of cancer. Once identified, these genetic changes can help oncologists choose targeted therapies that work best for that particular cancer profile.
When is NGS Recommended?
Doctors typically recommend NGS in situations where:
- Cancer is advanced or has spread and standard treatments are not delivering desired results.
- Targeted therapy might be an option based on the patient’s tumor profile.
- Rare or aggressive cancers require deeper investigation to find effective treatment strategies.
- Cancer has returned after initial treatment, and a new treatment plan needs to be crafted.
It’s especially useful for cancers such as:
- Lung cancer
- Ovarian cancer
- Prostate cancer
- Colon cancer
- Genetic and hereditary cancers
Types of NGS Tests
NGS can be performed in two main ways, depending on how the sample is collected:
- Tissue NGS
A biopsy sample from the tumor is collected and analyzed. This method offers high accuracy since it examines cancer cells directly from the tumor site.
- Liquid Biopsy NGS
A blood sample is used to detect fragments of tumor DNA circulating in the bloodstream. This is less invasive and can be useful when a biopsy is not possible or needs to be avoided.
NGS in India vs. Abroad
For years, NGS was primarily conducted in specialized laboratories overseas. These tests often accessed larger global genetic databases, which could offer broader insights—but at a much higher cost.
Today, many reputed Indian laboratories provide high-quality NGS testing at a fraction of the international cost, making it more accessible to patients. In some cases, the results are on par with global standards, especially for cancers that have well-studied mutation profiles.
How NGS Improves Cancer Treatment Outcomes
The biggest advantage of NGS is personalization. Instead of relying solely on trial-and-error methods, oncologists can:
Identify actionable mutations that match available targeted therapies.
- Avoid treatments that are unlikely to work for the patient’s cancer type.
- Explore clinical trials for therapies targeting specific genetic mutations.
- Monitor changes in tumor DNA over time to adjust treatment strategies.
- In short, NGS shifts cancer treatment from reactive to proactive, helping doctors act on precise data instead of generalized protocols.
Future Applications of NGS in Cancer Care
While NGS is already making a huge difference in cancer treatment, its potential is even greater:
- Early cancer detection before symptoms appear.
- Predicting cancer risk in individuals with a family history of certain cancers.
- Real-time monitoring of cancer progression or recurrence.
- Expanding targeted therapy options as more genetic mutations are studied and linked to new drugs.
Who Should Consider NGS Testing?
NGS may be recommended for:
- Patients diagnosed with advanced-stage cancer.
- Those with cancers known for specific gene mutations.
- Patients who have exhausted standard treatment options.
- Individuals with a family history of genetic cancers.
- It’s always best to discuss with an oncologist whether NGS could provide useful insights for your case.
Conclusion
Next Generation Sequencing is more than just a test—it’s a smarter, more personalized approach to cancer treatment. By understanding the genetic code of a tumor, doctors can match patients with the most effective therapies, avoid ineffective treatments, and even connect them to groundbreaking clinical trials.
With the availability of cost-effective, high-quality NGS testing in India, more patients now have access to this revolutionary tool in the fight against cancer.
Frequently Asked Questions (FAQ)
Q1: Is NGS painful?
No. NGS itself is not a painful procedure. It uses either a blood sample (liquid biopsy) or a tissue sample taken during a biopsy.
Q2: How long does it take to get NGS results?
Typically, results take 2–3 weeks, though some labs may deliver reports faster.
Q3: Can NGS be used for all types of cancer?
While not necessary for every cancer case, NGS is especially valuable for cancers known to have actionable genetic mutations, such as lung, ovarian, and colon cancers.
